A closer look at the new members of the CDC vaccine advisory panel
For more than a half-century, the Centers for Disease Control and Prevention have relied on outside experts to guide the agency’s recommendations on how
For more than a half-century, the Centers for Disease Control and Prevention have relied on outside experts to guide the agency’s recommendations on how
Sarepta said it was halting shipments of its Duchenne gene therapy for patients who can no longer walk, following the death of a second recipient.
Taxpayers will send an estimated $86 billion to Medicare Advantage insurers this year to pay for supplemental benefits for their members, or 17% of total
Sarepta said it was halting shipments of its Duchenne gene therapy for patients who can no longer walk, following the death of a second recipient.
For more than a half-century, the Centers for Disease Control and Prevention have relied on outside experts to guide the agency’s recommendations on how
A company like 23andMe can answer a lot of questions for an adoptee. But those answers come with a high cost to privacy.
A new $50 million NIH initiative to find the causes of autism faces questions about transparency and independence.
As a transfusion medicine physician, Jeremy W. Jacobs has increasingly faced requests for “unvaccinated donor blood.” So he and colleagues looked closer at what the…
Eliminating ACIP’s expertise on the eve of critical votes about flu and RSV vaccines will delay guidance, confuse clinicians, and cost lives.
As a transfusion medicine physician, Jeremy W. Jacobs has increasingly faced requests for “unvaccinated donor blood.” So he and colleagues looked closer at what the…
Sarepta said it was halting shipments of its Duchenne gene therapy for patients who can no longer walk, following the death of a second recipient.